SLC5A2 and infection: Finally, in regards to the reinitiation of SGLT2 inhibitors after urogenital infection, this class of drugs should be reinitiated as soon as possible after the infection is treated and there are no other contraindications, considering that delaying SGLT2 inhibitors reinitiation might lead to clinical deterioration in previously stable patients by deprivation of a disease-modifying drug [42].